Physician profile
Timothy Matway
NPI 1306133434
$7,668.43
in general payments reported to CMS, 2019-2025
40 companies · $794 in 2025
The $794 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,391 · 2020: $709 · 2021: $1,599 · 2022: $977 · 2023: $1,329 · 2024: $870 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,993.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,638.26 | 2021-2025 | Inceptiv, Accurian, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $882.93 | 2019-2024 | Senza |
| Abbott Laboratories | $709.76 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $498.13 | 2019-2023 | |
| Nalu Medical, INC. | $483.32 | 2021-2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $419.78 | 2019-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $405.26 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $368.63 | 2019-2023 | Ztlido |
| Vertos Medical, INC. | $348.45 | 2020-2023 | Mild Device Kit |
| Abbvie INC. | $192.21 | 2021-2025 | |
| Averitas Pharma INC. | $184.51 | 2023-2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $171.47 | 2019-2021 | |
| Globus Medical, INC. | $166.73 | 2025 | Senza, Vyrsa V1 |
| Mml US, INC. | $134.80 | 2022 | |
| Biodelivery Sciences International, INC. | $109.49 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Matway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.